Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea

BACKGROUND: Although the 13-valent pneumococcal conjugate vaccine (PCV13) showed good efficacy against pneumococcal disease in the the CAPiTA trial, the 23-valent pneumococcal polysaccharide vaccination (PPSV23) program has been ongoing for older adults aged ≥ 65 years in Korea since May of 2013. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jung Yeon, Seo, Yu Bin, Choi, Won Suk, Lee, Jacob, Noh, Ji Yun, Jeong, Hye Won, Kim, Woo Joo, Kim, Min Ja, Lee, Hee Young, Song, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428995/
https://www.ncbi.nlm.nih.gov/pubmed/28498857
http://dx.doi.org/10.1371/journal.pone.0177342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428995/
https://www.ncbi.nlm.nih.gov/pubmed/28498857
http://dx.doi.org/10.1371/journal.pone.0177342

Ejemplares similares